Cargando…
Impact of extent of parietal peritonectomy on oncological outcome after cytoreductive surgery and HIPEC
BACKGROUND: In peritoneal surface malignancy (PSM), in spite of optimal cytoreductive surgery (CRS), majority of recurrences that occur are intraperitoneal. In patients with PSM, studies employing fluorescent imaging and microscopic examination have shown normal looking peritoneum may harbor active...
Autores principales: | Somashekhar, S.P., Ashwin, K.R., Yethadka, Ramya, Zaveri, Shabber S., Ahuja, Vijay K, Rauthan, Amit, Rohit, Kumar C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881664/ https://www.ncbi.nlm.nih.gov/pubmed/31799371 http://dx.doi.org/10.1515/pp-2019-0015 |
Ejemplares similares
-
Evaluation of delay in time to adjuvant chemotherapy after HIPEC and its impact on oncological outcome in advanced epithelial ovarian cancer
por: Somashekhar, S.P., et al.
Publicado: (2020) -
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer with Peritoneal Metastasis—Indian Experience
por: S.P, Somashekhar, et al.
Publicado: (2021) -
Real-World Experience with Nivolumab in Metastatic Renal Cell Carcinoma Patients Who Have Progressed on Prior Therapies: A Single-Center Study from India
por: Rauthan, Amit, et al.
Publicado: (2022) -
Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy
por: Somashekhar, S.P., et al.
Publicado: (2018) -
Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases
por: Di Giorgio, Angelo, et al.
Publicado: (2016)